Not available
Quote | Prothena Corporation plc (NASDAQ:PRTA)
Last: | $20.26 |
---|---|
Change Percent: | 0.7% |
Open: | $19.93 |
Close: | $20.26 |
High: | $20.36 |
Low: | $19.55 |
Volume: | 333,356 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Prothena Corporation plc (NASDAQ:PRTA)
2024-07-03 23:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 13:00:00 ET Summary 21 new analysts joined in June and are highlighted today. Each is introduced with some details on their first investment thesis on Seeking Alpha and their background. Analysts cover a range of sectors including biotech, technology, consumer staples, ...
Message Board Posts | Prothena Corporation plc (NASDAQ:PRTA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PRTA News Article - Prothena Reports First Quarter 2023 Financial Results and Business | whytestocks | investorshangout | 05/04/2023 8:55:53 PM |
whytestocks: $PRTA News Article - Walgreens and Prothena Partner to Increase Access and Enrollment i | whytestocks | investorshangout | 04/13/2023 3:31:04 PM |
whytestocks: $PRTA News Article - Prothena Presents New Preclinical Data Supporting Best-in-Class Pr | whytestocks | investorshangout | 03/31/2023 5:55:49 PM |
whytestocks: $PRTA News Article - Prothena Announces Achievement of $40 Million Clinical Milestone P | whytestocks | investorshangout | 11/21/2022 9:21:06 PM |
znewcar1: $PRTA 87% v10,9M c58.00 f46,9M H59.17 ML25.02 gapNgo | znewcar1 | investorshangout | 09/29/2022 2:25:02 AM |
News, Short Squeeze, Breakout and More Instantly...
Prothena Corporation plc Company Name:
PRTA Stock Symbol:
NASDAQ Market:
Prothena Corporation plc Website:
2024-07-03 23:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-02 10:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target Prothena will initiate a Phase 1 clinical trial for PRX019 in 2024 Prothena Corporation plc (NASDAQ:PRTA),...